Metraipolis › archive › dc_17d2ba2bf2c2

HtrA2/Omi: potential therapeutic targets for neurodegenerative diseases — Europe PMC PMID:41608412

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41608412
DOI: 10.3389/fphar.2026.1705666
License (as archived): solo-consultazione
Archived: 2026-11-06T20:50:17.197Z
SHA-256 of the archived text: 4cd801092dd80a05cbe1863887b4be981bb6d0d2c105937d8b45ce1db173f7cb
Stable URL of this page: https://metraipolis.com/documento/dc_17d2ba2bf2c2

How to cite

HtrA2/Omi: potential therapeutic targets for neurodegenerative diseases — Europe PMC PMID:41608412 — Europe PMC (en), https://europepmc.org/article/MED/41608412 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_17d2ba2bf2c2 (Metraipolis archive dc_17d2ba2bf2c2, sha256 4cd801092dd80a05cbe1863887b4be981bb6d0d2c105937d8b45ce1db173f7cb)

BibTeX

@misc{dc17d2ba2bf2c2,
  title = {HtrA2/Omi: potential therapeutic targets for neurodegenerative diseases — Europe PMC PMID:41608412},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41608412},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_17d2ba2bf2c2; sha256 4cd801092dd80a05cbe1863887b4be981bb6d0d2c105937d8b45ce1db173f7cb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41608412. Agents can read the archived copy with the MCP tool read_document.